(Q35164769)

6 August 2017

1 reference

title

Motexafin gadolinium: a possible new radiosensitiser (English)

1 reference

6 August 2017

Patrick Rodrigus

1

1 reference

6 August 2017

language of work or name

English

0 references

publication date

1 July 2003

1 reference

Expert Opinion on Investigational Drugs

6 August 2017

published in

1 reference

6 August 2017

volume

12

1 reference

6 August 2017

issue

7

1 reference

6 August 2017

page(s)

1205-1210

1 reference

SR 4233 (tirapazamine): a new anticancer drug exploiting hypoxia in solid tumours

6 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.7.1205

Effects of Motexafin gadolinium on tumor metabolism and radiation sensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.7.1205

Multicenter phase Ib/II trial of the radiation enhancer motexafin gadolinium in patients with brain metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.7.1205

Phases IB and II multidose trial of gadolinium texaphyrin, a radiation sensitizer detectable at MR imaging: preliminary results in brain metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.7.1205

Texaphyrins: new drugs with diverse clinical applications in radiation and photodynamic therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.7.1205

Gadolinium(III) texaphyrin: a tumor selective radiation sensitizer that is detectable by MRI.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.7.1205

Redox cycling by motexafin gadolinium enhances cellular response to ionizing radiation by forming reactive oxygen species

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.7.1205

Motexafin gadolinium reacts with ascorbate to produce reactive oxygen species

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.7.1205

10.1517/13543784.12.7.1205

21 January 2018

Identifiers

DOI

1 reference

6 August 2017

1 reference